EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Dempsey Demystifies Regulatory Cycle at DIA Europe

Sheena Dempsey Speaks at DIA Europe 2018 Sheena Dempsey RWS Life Sciences Managing Director, S...
Continue Reading →
Europe

Tool ‘names and shames’ hidden drug trials

Institutions that fail to report the results of their drug and medical trials will be named on a new website. Trials Tracker logs which clinical trials have missed d...
Continue Reading →
Europe

Worldwide Clinical Trials Selects goBalto Platform for Study Startup

The leading provider of cloud-based clinical study startup solutions, announced today that Worldwide Clinical Trials (Worldwide) has chosen goBalto's end-to-end pla...
Continue Reading →
Europe

‘Vital’ UK remains part of EU clinical trials, say MPs

Continued participation in EU-wide clinical trials and the Horizon 2020 research programme is ‘vital’ to the UK’s life sciences sector, according to a new cross-par...
Continue Reading →
Europe

Patients Regain Sight With Stem Cell Treatment In U.K. Clinical Trial

Nearly three years ago, 86-year-old Douglas Waters developed severe vision problems. He was diagnosed with severe wet age-related macular degeneration(AMD), a chroni...
Continue Reading →
Europe

Clinical trial roadblocks: Patients, families anguish over being denied participation in cutting-edge studies

The news was devastating. Desperate for any hope to overcome terminal brain cancer, Esko teacher Jess Blake had sought enrollment in a clinical trial that seemed ...
Continue Reading →
Europe

Brexit boom ahead for Dutch clinical trials and human test subjects

The arrival of the European Medicines Agency in Amsterdam next year will be a major boost for the Netherlands’ own drugs testing sector, and moves are already being ...
Continue Reading →
Europe

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phas...
Continue Reading →
Europe

Proteomics launches diagnostic test leader ‘PromarkerD’

Proteomics International is engaged with potential partners to bring PromarkerD to market in mainland USA, Mexico, Japan, Australia, China and Europe. MedTech pione...
Continue Reading →
Europe

MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for Familial Chylomicronaemia Syndrome (FCS)

Akcea Therapeutics United Kingdom (UK) Ltd today announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Sche...
Continue Reading →
Quotient